• EN

    • -+ 0.00%
    -+ 0.00%
    -+ 0.00%

    How Lazard’s (LAZ) Swiss Investment Banking Hire Will Impact DACH Advisory Ambitions

    Simply Wall St·08/29/2026 06:23:27
    Listen to the news
    • Lazard recently expanded its Financial Advisory business by appointing Dr. Marco Superina as head of investment banking for Switzerland, based in Zurich and focused on advising Swiss and international clients across mergers and acquisitions, capital solutions and other strategic matters.
    • This hire, bringing in a veteran dealmaker with senior experience at UBS and Credit Suisse, signals a reinforced commitment to the DACH region and potentially deeper engagement with Switzerland’s corporate and financial sponsor community.
    • We’ll now examine how bringing in Dr. Superina to lead Swiss investment banking could influence Lazard’s broader investment narrative and outlook.

    We've uncovered the 12 dividend fortresses yielding 5%+ that don't just survive market storms, but thrive in them.

    Lazard Investment Narrative Recap

    To own Lazard, you need to be comfortable with a people heavy advisory and asset management model that depends on deal flow, fee resilience, and disciplined costs. The hire of Dr. Marco Superina looks directionally supportive of Lazard’s advisory ambitions in Europe, but against weaker recent profitability and margin pressure, it does not materially change the most immediate catalyst, which is execution on its growing advisory platform, or the key risk around elevated costs and high leverage.

    Among recent announcements, the US$200.0 million increase to Lazard’s share repurchase authorization in July 2026 stands out, especially given softer Q2 2026 earnings. Combined with ongoing senior hires such as Dr. Superina in Switzerland and earlier additions across healthcare and financial sponsors, investors are seeing a firm that is both returning capital and investing in its advisory footprint, with the short term catalyst still resting on whether these investments can translate into steadier earnings and better margin trends.

    Yet this expansion brings a risk investors should be aware of, particularly if compensation and hiring costs keep rising faster than...

    Read the full narrative on Lazard (it's free!)

    Lazard's narrative projects $4.6 billion revenue and $573.6 million earnings by 2029. This requires 12.6% yearly revenue growth and a $303.7 million earnings increase from $269.9 million today.

    Uncover how Lazard's forecasts yield a $48.50 fair value, a 11% upside to its current price.

    Exploring Other Perspectives

    LAZ 1-Year Stock Price Chart
    LAZ 1-Year Stock Price Chart

    Some of the lowest ranked analysts paint a much tougher picture, assuming earnings of about US$633.1 million by 2029 and a 9.1 times PE, so if you worry about fee pressure and talent costs, this Switzerland hire could either challenge or support that more pessimistic view.

    Explore 5 other fair value estimates on Lazard - why the stock might be worth 31% less than the current price!

    The Verdict Is Yours

    Don't just follow the ticker - dig into the data and build a conviction that's truly your own.

    Seeking Other Investments?

    Markets shift fast. These stocks won't stay hidden for long. Get the list while it matters:

    This article by Simply Wall St is general in nature. We provide commentary based on historical data and analyst forecasts only using an unbiased methodology and our articles are not intended to be financial advice. It does not constitute a recommendation to buy or sell any stock, and does not take account of your objectives, or your financial situation. We aim to bring you long-term focused analysis driven by fundamental data. Note that our analysis may not factor in the latest price-sensitive company announcements or qualitative material. Simply Wall St has no position in any stocks mentioned.